Synaptive Medical and General Atlantic Announce Strategic Partnership

TORONTO and NEW YORK (November 3, 2016) — Synaptive Medical, a leading medical device and technology company that pursues connections to transform the process of care, announced today that General Atlantic, a global growth equity firm, has made a strategic investment in the company. With over 35 years of experience investing in 250 growth companies and deep expertise in the healthcare and technology sectors, General Atlantic partners with entrepreneurs and management teams around the world to help them accelerate growth and become market leaders.

Read the full press release on the Synaptive website

Previous
Previous

Zucara Therapeutics Receives Cash Injection to Advance Novel Diabetes Drug Therapy to Prevent Hypoglycemia

Next
Next

CAAP Company: Komodo OpenLab Featured on 680 News